Genetic polymorphisms associated with steroids metabolism and insulin action in polycystic ovary syndrome

References

• Farrell K, Antoni MH. Insulin resistance, obesity, inflammation, and depression in polycystic ovary syndrome: biobehavioral mechanisms and interventions. Fertil Steril 2010;94:1565–1574.
   PubMed Web of Science ®Google Scholar
• The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19:41–47.
   PubMed Web of Science ®Google Scholar
• Sharp L, Cardy AH, Cotton SC, Little J. CYP17 gene polymorphisms: prevalence and associations with hormone levels and related factors. a HuGE review. Am J Epidemiol 2004;160:729–740.
   PubMed Web of Science ®Google Scholar
• Ito Y, Fisher CR, Conte FA, Grumbach MM, Simpson ER. Molecular basis of aromatase deficiency in an adult female with sexual infantilism and polycystic ovaries. Proc Natl Acad Sci USA 1993;90:11673–11677.
   PubMed Web of Science ®Google Scholar
• Ibáñez L, Ong KK, Mongan N, Jääskeläinen J, Marcos MV, Hughes IA et al. Androgen receptor gene CAG repeat polymorphism in the development of ovarian hyperandrogenism. J Clin Endocrinol Metab 2003;88:3333–3338.
   PubMed Web of Science ®Google Scholar
• Syrrou M, Georgiou I, Patsalis PC, Bouba I, Adonakis G, Pagoulatos GN. Fragile X premutations and (TA)n estrogen receptor polymorphism in women with ovarian dysfunction. Am J Med Genet 1999;84:306–308.
   PubMed Web of Science ®Google Scholar
• Westberg L, Baghaei F, Rosmond R, Hellstrand M, Landén M, Jansson M et al. Polymorphisms of the androgen receptor gene and the estrogen receptor beta gene are associated with androgen levels in women. J Clin Endocrinol Metab 2001;86:2562–2568.
   PubMed Web of Science ®Google Scholar
• Siegel S, Futterweit W, Davies TF, Concepcion ES, Greenberg DA, Villanueva R et al. A C/T single nucleotide polymorphism at the tyrosine kinase domain of the insulin receptor gene is associated with polycystic ovary syndrome. Fertil Steril 2002;78:1240–1243.
   PubMed Web of Science ®Google Scholar
• San Millán JL, Cortón M, Villuendas G, Sancho J, Peral B, Escobar-Morreale HF. Association of the polycystic ovary syndrome with genomic variants related to insulin resistance, type 2 diabetes mellitus, and obesity. J Clin Endocrinol Metab 2004;89:2640–2646.
   PubMed Web of Science ®Google Scholar
• Diamanti-Kandarakis E, Palioniko G, Alexandraki K, Bergiele A, Koutsouba T, Bartzis M. The prevalence of 4G5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in polycystic ovarian syndrome and its association with plasma PAI-1 levels. Eur J Endocrinol 2004;150:793–798.
   PubMed Web of Science ®Google Scholar
• World Health Organization Obesity: preventing and managing the global epidermic. Report of a WHO consultation on obesity. Geneva: World Health Organization; 1997.
   Google Scholar
• Legro RS, Castracane VD, Kauffman RP. Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls. Obstet Gynecol Surv 2004;59:141–154.
   PubMed Web of Science ®Google Scholar
• Kamel N, Tonyukuk V, Emral R, Corapçioglu D, Bastemir M, Güllü S. Role of ovary and adrenal glands in hyperandrogenemia in patients with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes 2005;113:115–121.
   PubMedGoogle Scholar
• Geloneze B, Repetto EM, Geloneze SR, Tambascia MA, Ermetice MN. The threshold value for insulin resistance (HOMA-IR) in an admixtured population IR in the Brazilian Metabolic Syndrome Study. Diabetes Res Clin Pract 2006;72:219–220.
   PubMed Web of Science ®Google Scholar
• Katsikis I, Karkanaki A, Misichronis G, Delkos D, Kandaraki EA, Panidis D. Phenotypic expression, body mass index and insulin resistance in relation to LH levels in women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 2011;156:181–185.
   PubMed Web of Science ®Google Scholar
• Pusalkar M, Meherji P, Gokral J, Chinnaraj S, Maitra A. CYP11A1 and CYP17 promoter polymorphisms associate with hyperandrogenemia in polycystic ovary syndrome. Fertil Steril 2009;92:653–659.
   PubMed Web of Science ®Google Scholar
• Marszalek B, Lacinski M, Babych N, Capla E, Biernacka-Lukanty J, Warenik-Szymankiewicz A et al. Investigations on the genetic polymorphism in the region of CYP17 gene encoding 5′-UTR in patients with polycystic ovarian syndrome. Gynecol Endocrinol 2001;15:123–128.
   PubMedGoogle Scholar
• Echiburú B, Pérez-Bravo F, Maliqueo M, Sánchez F, Crisosto N, Sir-Petermann T. Polymorphism T−> C (-34 base pairs) of gene CYP17 promoter in women with polycystic ovary syndrome is associated with increased body weight and insulin resistance: a preliminary study. Metab Clin Exp 2008;57:1765–1771.
   PubMed Web of Science ®Google Scholar
• Petry CJ, Ong KK, Michelmore KF, Artigas S, Wingate DL, Balen AH et al. Association of aromatase (CYP 19) gene variation with features of hyperandrogenism in two populations of young women. Hum Reprod 2005;20:1837–1843.
   PubMed Web of Science ®Google Scholar
• Rani A, Roy AC. Variation in the ERα and ERβ genes and genetic susceptibility to polycystic ovary syndrome. Fertil Steril 2005;84:S443.
   Google Scholar
• Bagos PG. Plasminogen activator inhibitor-1 4G/5G and 5,10-methylene-tetrahydrofolate reductase C677T polymorphisms in polycystic ovary syndrome. Mol Hum Reprod 2009;15:19–26.
   PubMed Web of Science ®Google Scholar
• Karadeniz M, Erdogan M, Berdeli A, Saygili F, Yilmaz C. 4G/5G polymorphism of PAI-1 gene and Alu-repeat I/D polymorphism of TPA gene in Turkish patients with polycystic ovary syndrome. J Assist Reprod Genet 2007;24:412–418.
   PubMed Web of Science ®Google Scholar
• Liu Q, Hong J, Cui B, Zhang Y, Gu W, Chi Z et al. Androgen receptor gene CAG(n) trinucleotide repeats polymorphism in Chinese women with polycystic ovary syndrome. Endocrine 2008;33:165–170.
   PubMedGoogle Scholar
• Xita N, Georgiou I, Lazaros L, Psofaki V, Kolios G, Tsatsoulis A. The synergistic effect of sex hormone-binding globulin and aromatase genes on polycystic ovary syndrome phenotype. Eur J Endocrinol 2008;158:861–865.
   PubMed Web of Science ®Google Scholar
• Hickey T, Chandy A, Norman RJ. The androgen receptor CAG repeat polymorphism and X-chromosome inactivation in Australian Caucasian women with infertility related to polycystic ovary syndrome. J Clin Endocrinol Metab 2002;87:161–165.
   PubMed Web of Science ®Google Scholar
• Kim JJ, Choung SH, Choi YM, Yoon SH, Kim SH, Moon SY. Androgen receptor gene CAG repeat polymorphism in women with polycystic ovary syndrome. Fertil Steril 2008;90:2318–2323.
   PubMedGoogle Scholar
• Xita N, Tsatsoulis A. Review: fetal programming of polycystic ovary syndrome by androgen excess: evidence from experimental, clinical, and genetic association studies. J Clin Endocrinol Metab 2006;91:1660–1666.
   PubMed Web of Science ®Google Scholar
• Simoni M, Tempfer CB, Destenaves B, Fauser BC. Functional genetic polymorphisms and female reproductive disorders: Part I: Polycystic ovary syndrome and ovarian response. Hum Reprod Update 2008;14:459–484.
   PubMed Web of Science ®Google Scholar
• Chen ZJ, Zhao H, He L, Shi Y, Qin Y, Shi Y et al. Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3. Nat Genet 2011;43:55–59.
   PubMed Web of Science ®Google Scholar